Skip to content

Author

Shu-Chun Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

P53 Competitively Binds P300 to Suppress HIF‐1α/TFRC‐Mediated Ferroptosis and Promote Doxorubicin Resistance in Breast Cancer

P53 promotes DOX resistance by suppressing HIF‐1α/P300‐mediated TFRC transcription and TFRC‐dependent ferroptosis, highlighting the P53/P300/HIF‐1α/TFRC axis as a potential therapeutic target in DOX‐resistant breast cancer.

Xiao-Jie Yu, L. Yao, Shu-Chun Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.